For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Angio-Medical Corp.

USPTO Granted Patents = 14

Forward Citations = 252

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Robert S Sinn (11 out of 12 patents)

Nicholas Catsimpoolas (11 out of 17 patents)

Ahmad R Kamarei (6 out of 6 patents)

4. Robert McCluer (5 out of 5 patents)

5. Michael I Klibaner (4 out of 4 patents)

6. Ann L Griffith (3 out of 3 patents)

7. James Evans (3 out of 3 patents)

8. Takashi Mise (1 out of 1 patent)

9. Sandor Szabo (1 out of 9 patents)

10. Meryl S Rubin (1 out of 1 patent)

11. Joseph Lane (1 out of 1 patent)

12. Haralambos P Gavras (1 out of 5 patents)

13. Christian C Haudenschild (1 out of 1 patent)

14. Denise Peton (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 5066496 - Composition and method for treatment of gastric and duodenal ulcers and (1991-11-19),

2. 4990333 - Method for healing bone damage (1991-02-05),

3. 4957741 - Method for the treatment of gastric ulcer (1990-09-18),

4. 4921838 - Angiogenic and blood perfusion inducing properties of amphiphilic (1990-05-01),

5. 4895838 - Method for provoking angiogenesis by administration of angiogenically (1990-01-23),

6. 4888324 - Method for enhancing angiogenesis with lipid containing molecules (1989-12-19),

7. 4879312 - Method for enhancing or provoking angiogenesis using angiogenically (1989-11-07),

8. 4879114 - Lipids from omentum and methods for cosmetic use (1989-11-07),

9. 4778787 - Method for treatment of angina and myocardial infarctions with omental (1988-10-18),

10. 4776173 - Method for extracting a substance from animal derived material (1988-10-11),

11. 4769362 - Increased vascular perfusion following administration of lipids (1988-09-06),

12. 4767746 - Method for enhancement of healing of epithelial wounds in mammals (1988-08-30),

13. 4749522 - Supercritical fluid extraction of animal derived materials (1988-06-07),

14. 4710490 - Compositions containing ganglioside molecules with enhanced angiogenic (1987-12-01),

Company Overview

Angio-Medical Corp. is a New York-based company specializing in the development and manufacturing of innovative medical devices aimed at enhancing patient care in the vascular and interventional fields. The organization focuses on advanced technologies that improve diagnostic and therapeutic procedures, contributing to better clinical outcomes. With a commitment to research and development, Angio-Medical Corp. plays a significant role in the evolution of medical solutions that address complex health challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

14 Patents

#531 in New York, NY

#1,296 in New York

#22,319 in US

#42,249 in the World

New York, NY, United States of America

Angio-Medical Corp.

Forward Citations = 252

14 inventors:

Robert S Sinn (11 out of 12 patents)

Nicholas Catsimpoolas (11 out of 17 patents)

Ahmad R Kamarei (6 out of 6 patents)

4. Robert McCluer (5 out of 5 patents)

5. Michael I Klibaner (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Angio-Medical Corp.. Retrieved from https://idiyas.com/company/angio-medical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…